| Name | Gastric Inhibitory Polypeptide (3-42) (human) trifluoroacetate salt |
|---|---|
| Synonyms |
GLU-GLY-THR-PHE-ILE-SER-ASP-TYR-SER-ILE-ALA-MET-ASP-LYS-ILE-HIS-GLN-GLN-ASP-PHE-VAL-ASN-TRP-LEU-LEU-ALA-GLN-LYS-GLY-LYS-LYS-ASN-ASP-TRP-LYS-HIS-ASN-ILE-THR-GLN
EGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ GIP , human MFCD18782440 Gastric Inhibitory Polyptide (human)、GIP( H-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH |
| Description | GIP (3-42), human acts as a glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist, moderating the insulin secreting and metabolic actions of GIP in vivo[1]. |
|---|---|
| Related Catalog | |
| In Vitro | The incretin hormone GIP is rapidly degraded in the circulation by dipeptidyl peptidase IV (DPP IV) forming the N-terminally truncated peptide GIP(3-42)[1]. |
| References |
| Molecular Formula | C216H325F3N58O65S |
|---|---|
| Molecular Weight | 4749.9 |
| Storage condition | -20°C |